The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (...
Keep Reading →
May 31 - Stock Analysis
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 17 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Keep Reading →
December 7 - Hedge Funds, News
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment...
Keep Reading →
October 22 - Hedge Funds, News
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Keep Reading →
June 10 - Hedge Funds, News
"October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being '08 and the Crash of '87...
Keep Reading →
March 30 - Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
December 9 - Hedge Funds, News
Warren Buffett is arguably the greatest investor of all time.
Keep Reading →
November 12 - News
What happened: Shares of solar manufacturer SunPower Corp.
Keep Reading →
February 15 - Market Movers, News
In this article we are going to share highlights from Jana Partners' 2017 Q4 investor letter.
Keep Reading →
January 25 - Hedge Fund Investor Letters, Hedge Funds, News
The top 10 generic pharmaceutical companies in 2017 operate in the relatively recession-proof pharmaceuticals industry which is immune from the vagaries of economic cycles.
Keep Reading →
December 13 - Lists, News
Out of hundreds of healthcare stocks that are trading on the U.S stock market, we have selected the top 75 healthcare dividend stocks to invest in.
Keep Reading →
July 17 - Dividend Stocks, News
"U.S. equities traded higher on Wednesday as investors cheered the Federal Reserve's plan for scaling back its massive $4.5 trillion balance sheet.
Keep Reading →
May 24 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined with progestin/estrogen.
Keep Reading →
March 20 - News, Stock Analysis
David Tepper of Appaloosa Management is one of the most closely followed hedge fund managers in the world.
Keep Reading →
March 13 - Hedge Fund Analysis, Hedge Funds, News
The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V.
Keep Reading →
March 2 - News, Stock Analysis
An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration.
Keep Reading →
March 1 - News, Stock Analysis
What are the 10 states with the highest opioid abuse rates? Opioid pain killers are generally a good thing.
Keep Reading →
February 26 - Lists, News
Back in 2008, billionaire Warren Buffett made a bet that hedge funds will underperform index funds over the following decade.
Keep Reading →
February 23 - Activism, Hedge Funds, News
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories.
Keep Reading →
February 22 - News, Stock Analysis
Notable value investor and billionaire Michael Price recently has revealed his equity portfolio as of the end of 2016 via a 13F filing submitted with the SEC. Mr.
Keep Reading →
February 20 - Hedge Funds, News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has announced the approval of AirDuo RespiClick and ArmonAir RespiClick by the U.S. Food and Drug Administration.
Keep Reading →
February 2 - News, Stock Analysis
A U.S. court has rejected four claims of patent infringement from Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
Keep Reading →
January 31 - News, Stock Analysis
Patients with severe pain that demands long-term, around-the-clock treatment now have a new medication to try.
Keep Reading →
January 19 - News, Stock Analysis
Brower Piven, a law firm specializing in securities litigation, is sending out an appeal reminding investors of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) that the...
Keep Reading →
December 30 - News, Stock Analysis
The Securities and Exchange Commission has revealed that Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to pay more than $500 million after being found to have...
Keep Reading →
December 28 - News, Stock Analysis
Billionaire Michael Price is an American value investor and hedge fund manager who founded MFP Investors, a New York-based investment fund, in 1988. Mr.
Keep Reading →
December 22 - Hedge Funds, News
John Paulson founded New York-based investment management firm Paulson & Company in 1994.
Keep Reading →
December 17 - Hedge Fund Analysis, Hedge Funds, News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shareholders were treated to an unpleasant surprise by generics CEO Siggi Olafsson, who is said to be jumping ship.
Keep Reading →
December 7 - News, Stock Analysis
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Keep Reading →
November 25 - Hedge Funds, News
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY) on a long-lasting class...
Keep Reading →
November 23 - News, Stock Analysis
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is alleged to have bought its way into boosting its sales in foreign countries including Russia, Mexico, and Ukraine.
Keep Reading →
November 16 - News, Stock Analysis
It seems like Deja Vu all over again as pollsters and conventional wisdom were again proven wrong.
Keep Reading →
November 9 - Market Movers, News
Although the non-farm payrolls for October came in worse than expected, at 161,000 versus the expected 175,000, volatility remains low on the Street as all three indexes are close...
Keep Reading →
November 4 - Market Movers, News
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) will have to wait for a court ruling over its IP protection for its lifelong multiple sclerosis therapy, Copaxone.
Keep Reading →
November 1 - News
Among the stocks that traders are watching are Toyota Motor Corp (ADR) (NYSE:TM), Martin Marietta Materials, Inc.
Keep Reading →
October 26 - Market Movers, News
Reports in the pharmaceutical space indicate that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) might be planning to acquire South Korea biosimilar giant Celltrion.
Keep Reading →
October 19 - News, Stock Analysis
Teva Pharmaceutical Industries Ltd.
Keep Reading →
October 7 - News, Stock Analysis
Among the stocks grabbing trader's attention include iRobot Corporation (NASDAQ:IRBT), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Intel Corporation (NASDAQ:INTC), ...
Keep Reading →
September 15 - Commodities, Market Movers, News
After Friday's sharp drop in equity prices, more investors are keeping tabs on the market to see whether the recent interest rate fears will cause the indexes to enter into correction...
Keep Reading →
September 12 - Market Movers, News
Interest rate-sensitive financial stocks are in the spotlight today after previously-dovish Boston Federal Reserve President Eric Rosengren said that "a reasonable case can be...
Keep Reading →
September 9 - Market Movers, News
Billionaire Larry Robbins' famed hedge fund Glenview Capital recently has submitted its 13F filing with SEC for the reporting period ended June 30, revealing a US equity portfolio...
Keep Reading →
September 3 - Hedge Funds, News
John Paulson is an American hedge fund manager and billionaire who founded his investment firm Paulson & Co in 1994 with only $2 million and one employee.
Keep Reading →
August 27 - Hedge Fund Analysis, Hedge Funds, News
Tiger Management was founded in 1980 by billionaire and legendary investor Julian Robertson, who later closed the fund to outside investors and now manages his own money, as well...
Keep Reading →
August 23 - Hedge Fund Analysis, Hedge Funds, News
London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC.
Keep Reading →
August 10 - Hedge Fund Analysis, Hedge Funds, News
Caught between a rock and a hard place due to the Brexit decision in June, the Bank of England announced today that it will cut interest rates and expand its stimulus measures...
Keep Reading →
August 4 - Earnings Report, Market Movers, News
It's been a relatively quiet morning on Wall Street as all three index futures are close to flat.
Keep Reading →
July 13 - Market Movers, News
With the end of the quarter rapidly approaching, it seems that a short squeeze/bear market rally could be on deck as bargain hunters snap up stocks and momentum players take ...
Keep Reading →
June 28 - Market Movers, News
Crude prices are 1.5% lower today as traders are taking profits on yesterday's run-up.
Keep Reading →
June 21 - Market Movers, News